CRISPR/Cas9 knockout and editing of the major cysteine protease in Entamoeba histolytica
Preprint
Abstract
Entamoeba histolytica is the cause of amoebiasis, a diarrheal infection that is a significant source of morbidity and mortality. Despite its importance to human health, the basic mechanism of disease is poorly understood. E. histolytica is dramatically understudied, even in comparison to other understudied parasites, due to challenging features of its genome and the relative paucity of genetic tools. A major limitation is the historical lack of gene knockouts or manipulation of the endogenous genome. While CRISPR/Cas9 has led to major advances in the tractability of numerous parasites, until recently, it was not applied in E. histolytica, except for the demonstration of editing of an episomal plasmid. In this study, we further developed CRISPR/Cas9 and demonstrated the successful targeting of the endogenous cysteine protease 5 (CP5) gene, a major virulence factor. Further, we demonstrated successful CRISPR/Cas9-based editing of this locus, which represents the very first successful editing of the endogenous genome. In the course of these approaches, we developed the viral skip peptide approach as well as a suite of endogenous promoters to drive tunable levels of gene expression. We also performed the most extensive empirical testing of nuclear localization signals in E. histolytica that has been done. Thus, this work demonstrates effective CRISPR/Cas9-based manipulation of the endogenous genome, together with significant advances to the overall genetic toolkit that extend beyond CRISPR/Cas9. These great improvements in the tractability of E. histolytica thus set the stage for future studies to better define its virulence.Keywords
Funding Information
- National Institutes of Health (1R01AI189918)
- National Institutes of Health (1R01AI146914)
This publication has 52 references indexed in Scilit:
- Multiple types of nuclear localization signals in Entamoeba histolyticaBiochemistry and Biophysics Reports, 2024
- Growth and Genetic Manipulation of Entamoeba histolyticaCurrent Protocols, 2022
- Development of a CRISPR/Cas9 system in Entamoeba histolytica: proof of conceptInternational Journal for Parasitology, 2020
- Antiamoebic drugs for treating amoebic colitisCochrane Database of Systematic Reviews, 2019
- Destabilization domain approach adapted for regulated protein expression in the protozoan parasite Entamoeba histolyticaInternational Journal for Parasitology, 2014
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- DNA repair mechanisms in eukaryotes: Special focus in Entamoeba histolytica and related protozoan parasitesInfection, Genetics and Evolution, 2009
- Stable episomal transfection of Entamoeba histolyticaMolecular and Biochemical Parasitology, 1995
- Nucleotide sequence organisation and analysis of the nuclear ribosomal DNA circle of the protozoan parasite Entamoeba histolyticaMolecular and Biochemical Parasitology, 1994
- A new medium for the axenic cultivation of Entamoeba histolytica and other EntamoebaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1978